Loading...

Shirley Tsunoda

TitleClinical Professor
InstitutionUniversity of California San Diego
DepartmentSchool of Pharmacy and Pharmaceutical Science
Address9500 Gilman Drive #0714
La Jolla CA 92093
Phone858-822-6629
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yang J, Patel M, Nikanjam M, Capparelli EV, Tsunoda S, Greenberg HE, Penzak SR, Aubrey Stoch S, Bertino JS, Nafziger AN, Ma JD. Midazolam Single Time Point Concentrations to Estimate Exposure and Cytochrome P450 (CYP) 3A Constitutive Activity Utilizing Limited Sampling Strategy With a Population Pharmacokinetic Approach. J Clin Pharmacol. 2018 Apr 17. PMID: 29663428.
      View in: PubMed
    2. Momper JD, Tsunoda S, Ma JD. Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans. J Clin Pharmacol. 2016 07; 56 Suppl 7:S82-98. PMID: 27385182.
      View in: PubMed
    3. Masters JC, Harano DM, Greenberg HE, Tsunoda S, Jang IJ, Ma JD. Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotyping. Ther Drug Monit. 2015 Feb; 37(1):84-9. PMID: 25004135; PMCID: PMC4282980.
    4. Tai W, Gong SL, Tsunoda S, Greenberg HE, Gorski JC, Penzak SR, Stoch SA, Ma JD. Evaluation of partial area under the concentration time curve to estimate midazolam apparent oral clearance for cytochrome P450 3A phenotyping. Drug Metabol Drug Interact. 2013; 28(4):217-23. PMID: 24114901.
      View in: PubMed
    5. Nguyen AN, Hoffman JT, Tsunoda S, Jang IJ, Ma JD. Evaluation of intravenous midazolam limited sampling models to determine area under the concentration time curve during cytochrome P450 3A baseline, inhibition and induction or activation. Int J Clin Pharmacol Ther. 2012 Jul; 50(7):468-75. PMID: 22541751.
      View in: PubMed
    6. Nguyen CM, Mendes M, Tsunoda S, Ma JD. Interleukin-28B genotype testing to determine response to the combination of pegylated-interferon and ribavirin for the treatment of hepatitis C virus. PLoS Curr. 2011 Jan 08; 3:RRN1207. PMID: 21278901; PMCID: PMC3024597.
    7. Ma JD, Tsunoda S, Bertino JS, Trivedi M, Beale KK, Nafziger AN. Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation. Clin Pharmacokinet. 2010 Apr; 49(4):223-37. PMID: 20214407.
      View in: PubMed
    8. Patel RA, Lipton HL, Cutler TW, Smith AR, Tsunoda S, Stebbins MR. Cost minimization of medicare part D prescription drug plan expenditures. Am J Manag Care. 2009 Aug; 15(8):545-53. PMID: 19670958.
      View in: PubMed
    9. Harris RZ, Jang GR, Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokinet. 2003; 42(13):1071-88. PMID: 14531721.
      View in: PubMed
    10. Kim JS, Nafziger AN, Tsunoda S, Choo EE, Streetman DS, Kashuba AD, Kulawy RW, Beck DJ, Rocci ML, Wilkinson GR, Greenblatt DJ, Bertino JS. Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniques. J Clin Pharmacol. 2002 Apr; 42(4):376-82. PMID: 11936561.
      View in: PubMed